Engitix was created in 2016 to commercialise cutting-edge ECM research at the Institute for Liver and Digestive Health, Division of Medicine, University College London (UCL) and is now a growing biotechnology company with over 30 employees.
Engitix Ltd., a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, April...